Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cerebral Glioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04406610
What this trial is testing

CAR-T Cell Immunotherapy for GD2 Positive Glioma Patients

Who this might be right for
Glioma of BrainCAR-T Cell Immunotherapy
Fuda Cancer Hospital, Guangzhou
Testing effectiveness (Phase 2)Study completedNCT00006080
What this trial is testing

Fenretinide in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Large-scale testing (Phase 3)Study completedNCT00004259
What this trial is testing

Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 230
Testing effectiveness (Phase 2)Study completedNCT00003574
What this trial is testing

Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Early research (Phase 1)Study completedNCT00157703
What this trial is testing

G207 Followed by Radiation Therapy in Malignant Glioma

Who this might be right for
Malignant Glioma
MediGene 9
Early research (Phase 1)Ended earlyNCT00880061
What this trial is testing

An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma

Who this might be right for
Brain NeoplasmGlioma
National Institute of Neurological Disorders and Stroke (NINDS) 7
Early research (Phase 1)Study completedNCT02313272
What this trial is testing

Hypofractionated Stereotactic Irradiation (HFSRT) With Pembrolizumab and Bevacizumab for Recurrent High Grade Gliomas

Who this might be right for
Malignant Glioma
H. Lee Moffitt Cancer Center and Research Institute 32
Testing effectiveness (Phase 2)Looking for participantsNCT07680439
What this trial is testing

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

Who this might be right for
Diffuse Intrinsic Pontine GliomaDIPGBrain Tumor+9 more
BrainChild Bio, Inc 75
Not applicableStudy completedNCT00214175
What this trial is testing

Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy

Who this might be right for
GliomaBrain Neoplasms
University of Wisconsin, Madison 44
Not applicableStudy completedNCT04860934
What this trial is testing

Dual Task Training On Children With Ataxia After Medulloblastoma Resection

Who this might be right for
Medulloblastoma, ChildhoodChildhood Cancer
Children's Cancer Hospital Egypt 57357 30
Early research (Phase 1)Study completedNCT00004028
What this trial is testing

Carmustine in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Early research (Phase 1)Ended earlyNCT01088763
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more
National Cancer Institute (NCI) 129
Early research (Phase 1)Study completedNCT00031083
What this trial is testing

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Who this might be right for
Glioblastoma MultiformeAnaplastic AstrocytomaOligoastrocytoma, Mixed+1 more
Biogen 12
Early research (Phase 1)Ended earlyNCT01009866
What this trial is testing

Study of Immunotoxin, MR1-1

Who this might be right for
Supratentorial Malignant Brain Tumor
Darell D. Bigner, MD, PhD 9
Testing effectiveness (Phase 2)Study completedNCT00720356
What this trial is testing

Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Brain and Central Nervous System Tumors
Northwestern University 115
Testing effectiveness (Phase 2)Study completedNCT00124657
What this trial is testing

Erlotinib and Radiation Therapy in Treating Young Patients With Newly Diagnosed Glioma

Who this might be right for
Brain and Central Nervous System Tumors
St. Jude Children's Research Hospital 62
Testing effectiveness (Phase 2)Looking for participantsNCT04977375
What this trial is testing

Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Chirag G. Patil 10
Testing effectiveness (Phase 2)Study completedNCT00019422
What this trial is testing

Lobradimil and Carboplatin in Treating Children With Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT07179328
What this trial is testing

Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard Chemotherapy

Who this might be right for
GBMGlioblastoma Multiforme (GBM)Glioblastoma Multiforme of Brain+5 more
Sunnybrook Health Sciences Centre 10
Next Page